Moderna vaccine
-
Moderna says skin cancer vaccine trial a successSpeed Read The experimental vaccine successfully reduced the recurrence of melanoma, the company said
By Peter Weber, The Week US Published
Speed Read -
Stronger, faster, better: the new mRNA flu vaccineThe explainer The jab may be new and improved
By Devika Rao, The Week US Published
The explainer -
How close are we to a norovirus vaccine?Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
Today's Big Question -
FDA OKs new Covid vaccine, available soonSpeed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
Speed read -
You can now get a new Covid booster shot. Should you?Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber, The Week US Published
-
Lyme disease: vaccine could halt rise of tick-borne diseasefeature Experts have issued a warning as cases rise in the UK
By Chas Newkey-Burden, The Week UK Published
feature -
Is this the end of Covid?Talking Point WHO gives most upbeat assessment yet of the global battle against the virus
By Sorcha Bradley, The Week UK Last updated
Talking Point -
Will new ‘bivalent booster’ head off a winter Covid wave?Today's Big Question The jab combines the original form of the Covid vaccine with a version tailored for Omicron
By The Week Staff Published
Today's Big Question -
What Covid vaccines cost - and the countries paying over the oddsfeature Figures suggest that quicker vaccine rollouts are pay to play
By The Week Staff Last updated
feature -
How vaccines can be ‘tweaked’ to combat new Covid variantsfeature Spread of South Africa strain of coronavirus has intensified efforts to boost jab efficacy
By Chas Newkey-Burden, The Week UK Published
feature
